Bridging the gap from target to lead. Next generation antibody development.
“The success of next generation antibody drug development relies on comprehensive discovery technologies and strategies. YUMAB bridges the gap between research innovation and novel therapies. Their advanced discovery platform provides access to challenging targets, enables new formats, and accelerates the development of human antibodies at a high success rate. From target discovery to fully characterized lead – their experienced team leads biotech and pharma teams worldwide through the development process as your trusted, de-risking partner.”